Home / Tag Archives: EMD Serono

Tag Archives: EMD Serono

December, 2017

  • 27 December

    HTG Molecular Diagnostics Expands Collaboration with Merck KGaA

    TUCSON, Ariz. and DARMSTADT, Germany, Dec. 26, 2017 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications today announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany, a leading science and technology company. The Master Collaboration …

May, 2017

November, 2016

March, 2016

May, 2015

  • 12 May

    FDA Fast Tracks Merck KGaA’s Pancreatic Cancer Candidate

    The US Food and Drug Administration (FDA) has granted Fast Track designation to Merck KGaA and partner Threshold Pharmaceuticals’ investigational pancreatic cancer drug. The companies won Fast Track status for the development of evofosfamide, administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally …